Correlation Between Biomarin Pharmaceutical and Keros Therapeutics
Can any of the company-specific risk be diversified away by investing in both Biomarin Pharmaceutical and Keros Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Biomarin Pharmaceutical and Keros Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Biomarin Pharmaceutical and Keros Therapeutics, you can compare the effects of market volatilities on Biomarin Pharmaceutical and Keros Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Biomarin Pharmaceutical with a short position of Keros Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Biomarin Pharmaceutical and Keros Therapeutics.
Diversification Opportunities for Biomarin Pharmaceutical and Keros Therapeutics
-0.74 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Biomarin and Keros is -0.74. Overlapping area represents the amount of risk that can be diversified away by holding Biomarin Pharmaceutical and Keros Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Keros Therapeutics and Biomarin Pharmaceutical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Biomarin Pharmaceutical are associated (or correlated) with Keros Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Keros Therapeutics has no effect on the direction of Biomarin Pharmaceutical i.e., Biomarin Pharmaceutical and Keros Therapeutics go up and down completely randomly.
Pair Corralation between Biomarin Pharmaceutical and Keros Therapeutics
Given the investment horizon of 90 days Biomarin Pharmaceutical is expected to under-perform the Keros Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Biomarin Pharmaceutical is 2.0 times less risky than Keros Therapeutics. The stock trades about -0.21 of its potential returns per unit of risk. The Keros Therapeutics is currently generating about -0.09 of returns per unit of risk over similar time horizon. If you would invest 6,073 in Keros Therapeutics on August 28, 2024 and sell it today you would lose (415.00) from holding Keros Therapeutics or give up 6.83% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Biomarin Pharmaceutical vs. Keros Therapeutics
Performance |
| Timeline |
| Biomarin Pharmaceutical |
| Keros Therapeutics |
Biomarin Pharmaceutical and Keros Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Biomarin Pharmaceutical and Keros Therapeutics
The main advantage of trading using opposite Biomarin Pharmaceutical and Keros Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Biomarin Pharmaceutical position performs unexpectedly, Keros Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Keros Therapeutics will offset losses from the drop in Keros Therapeutics' long position.| Biomarin Pharmaceutical vs. Alnylam Pharmaceuticals | Biomarin Pharmaceutical vs. Exelixis | Biomarin Pharmaceutical vs. Halozyme Therapeutics | Biomarin Pharmaceutical vs. Arrowhead Pharmaceuticals |
| Keros Therapeutics vs. Ideaya Biosciences | Keros Therapeutics vs. AnaptysBio | Keros Therapeutics vs. MeiraGTx Holdings PLC | Keros Therapeutics vs. Janux Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.
Other Complementary Tools
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Stocks Directory Find actively traded stocks across global markets |